The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus
Bioorganic & Medicinal Chemistry · 2023
DOI: 10.1016/j.bmc.2023.117239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2023. Verfasst von Ana C Puhl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Collaborations Pharmaceuticals, Inc., 840, Main Campus Drive, Lab 3510, Raleigh, NC 27606, USA. Electronic address: ana@collaborationspharma.com. Hauptthemen laut MEDLINE: Chikungunya Fever, Chikungunya virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCIH NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Chikungunya virus (CHIKV) is the etiological agent of chikungunya fever, a (re)emerging arbovirus infection, that causes severe and often persistent arthritis, as well as representing a serious health concern worldwide for which no antivirals are currently available. Despite efforts over the last decade to identify and optimize new inhibitors or to reposition existing drugs, no compound has progressed to clinical trials for CHIKV and current prophylaxis is based on vector control, which has shown limited success in containing the virus. Our efforts to rectify this situation were initiated by screening 36 compounds using a replicon system and ultimately identified the natural product derivative 3-methyltoxoflavin with activity against CHIKV using a cell-based assay (EC50 200 nM, SI = 17 in Huh-7 cells). We have additionally screened 3-methyltoxoflavin against a panel of 17 viruses and showed that it only additionally demonstrated inhibition of the yellow fever virus (EC50 370 nM, SI = 3.2 in Huh-7 cells). We have also showed that 3-methyltoxoflavin has excellent in vitro human and mouse microsomal metabolic stability, good solubility and high Caco-2 permeability and it is not likely to be a P-glycoprotein substrate. In summary, we demonstrate that 3-methyltoxoflavin has activity against CHIKV, good in vitro absorption, distribution, metabolism and excretion (ADME) properties as well as good calculated physicochemical properties and may represent a valuable starting point for future optimization to develop inhibitors for this and other related viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Collaborations Pharmaceuticals, Inc., 840, Main Campus Drive, Lab 3510, Raleigh, NC 27606, USA. Electronic address: ana@collaborationspharma.com.
- Sao Carlos Institute of Physics, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos, SP 13563-120, Brazil.
- Department of Virology, Oswaldo Cruz Foundation, Aggeu Magalhães Institute, Av. Prof. Moraes Rego, s/n - Cidade Universitária, Recife, PE, 50670-420, Brazil.
- Collaborations Pharmaceuticals, Inc., 840, Main Campus Drive, Lab 3510, Raleigh, NC 27606, USA.
Förderung
- NCCIH NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
- Russell Sage Foundation
- National Center for Complementary and Integrative Health
Zitieren
APA
Puhl, A. C., Fernandes, R. S., Godoy, A. S., Gil, L. H. V. G., Oliva, G., & Ekins, S. (2023). The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2023.117239
Vancouver
Puhl AC, Fernandes RS, Godoy AS, Gil LHVG, Oliva G, Ekins S. The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus. Bioorganic & Medicinal Chemistry. 2023. doi:10.1016/j.bmc.2023.117239
BibTeX
@article{Puhl2023,
author = {Puhl, Ana C and Fernandes, Rafaela S and Godoy, Andre S and Gil, Laura H V G and Oliva, Glaucius and Ekins, Sean},
title = {The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus},
journal = {Bioorganic & Medicinal Chemistry},
year = {2023},
doi = {10.1016/j.bmc.2023.117239}
}
EUVIMED